Conversely, GIIA plays an antitumorigenic role in gastric cancer, since its overexpression inhibited gastric cancer invasion and metastasis through the Wnt/β-catenin signaling pathway [76], and it has been associated with improved patient survival [70,77]. This evidence concerns the gene GANAB and gastric cancer.